Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Elsevier uses machine learning to benefit pharmacovigilance

Posted on November 7th, 2019 by in Pharmacovigilance

Monitoring the scientific literature for adverse drug reactions (ADRs) is critical to maintaining drug safety, and there is no room for error. As regulations tighten, pharmacovigilance teams are seeking better strategies and methods for ensuring that all ADRs are identified in the most effective and efficient way possible.

(more…)

How Big Data Transforms Reactive Drug Safety to Proactive Pharmacovigilance

Posted on March 7th, 2019 by in Pharma R&D

Adverse drug reactions can be costly and cost is just the tip of the iceberg.  This is highlighted by an FDA website which cites troubling statistics such as the 100k deaths and over 2 million serious adverse drug reactions experienced each year…

(more…)

Are Drug-Drug Interactions Today’s Biggest Health Threat?

Posted on October 16th, 2018 by in Pharma R&D

The use of prescription medicines is sharply on the rise. Over the past decade, the number of adults taking over-the-counter medicines has sunk, while the number of prescription drug users has increased by more than 30 percent. (more…)

Doing our part to improve drug safety

Posted on October 2nd, 2018 by in Pharma R&D

Pharmacovigilance and drug safety teams are never short of work. There’s a vast amount of peer-reviewed literature to sift through for adverse event information. Over 800,000 pharmacology and biomedicine articles (more…)

  1. 1
  2. 2
  3. 3
  4. 14